FR15C0080I2 - Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 - Google Patents

Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52

Info

Publication number
FR15C0080I2
FR15C0080I2 FR15C0080C FR15C0080C FR15C0080I2 FR 15C0080 I2 FR15C0080 I2 FR 15C0080I2 FR 15C0080 C FR15C0080 C FR 15C0080C FR 15C0080 C FR15C0080 C FR 15C0080C FR 15C0080 I2 FR15C0080 I2 FR 15C0080I2
Authority
FR
France
Prior art keywords
hpv
type
vaccine against
against hpv16
hpv18
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR15C0080C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0413510.9A external-priority patent/GB0413510D0/en
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/fr
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of FR15C0080I1 publication Critical patent/FR15C0080I1/fr
Application granted granted Critical
Publication of FR15C0080I2 publication Critical patent/FR15C0080I2/fr
Active legal-status Critical Current

Links

FR15C0080C 2004-06-16 2015-12-04 Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 Active FR15C0080I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413510.9A GB0413510D0 (en) 2004-06-16 2004-06-16 Vaccine
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
PCT/EP2005/006461 WO2005123125A1 (fr) 2004-06-16 2005-06-14 Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52

Publications (2)

Publication Number Publication Date
FR15C0080I1 FR15C0080I1 (fr) 2016-08-01
FR15C0080I2 true FR15C0080I2 (fr) 2016-10-28

Family

ID=86656254

Family Applications (1)

Application Number Title Priority Date Filing Date
FR15C0080C Active FR15C0080I2 (fr) 2004-06-16 2015-12-04 Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52

Country Status (2)

Country Link
CY (3) CY2015047I1 (fr)
FR (1) FR15C0080I2 (fr)

Also Published As

Publication number Publication date
FR15C0080I1 (fr) 2016-08-01
CY2015048I1 (el) 2016-06-22
CY2015049I1 (el) 2016-06-22
CY2015047I2 (el) 2016-06-22
CY2015049I2 (el) 2016-06-22
CY2015047I1 (el) 2016-06-22
CY2015048I2 (el) 2016-06-22

Similar Documents

Publication Publication Date Title
FR15C0082I2 (fr) Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52
ECSP045300A (es) Antígenos virales
DK1375670T3 (da) Rekombinante mæslingevira, der udtrykker epitoper af RNA-viras antigener, samt anvendelse af de rekombinante vira til fremstilling af vaccinesammensætninger
AP2313A (en) Inhibitors of hepatitis C virus RNA-dependent RNA ploymerase, and compositions and treatments using the same.
PL2281831T3 (pl) Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
IL189329A (en) The vaccine against dengue fever virus infection has been used and used
BRPI0309631A2 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3,e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
WO2010047830A3 (fr) Agent permettant le traitement du virus de l'hépatite c
WO2009039248A3 (fr) Méthodes de traitement d'une infection par un virus de la famille des flaviviridae et compositions pour le traitement d'une infection par un virus de la famille des flaviviridae
BRPI0811499A2 (pt) Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
HUS1500061I1 (hu) A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
EP1723238A4 (fr) Virus oncolytiques modifies
WO2007130616A3 (fr) Polyamides destinés au traitement du papillomavirus humain
EP1765330A4 (fr) Derives de pyranoindole et utilisation de ceux-ci pour le traitement d'une maladie ou d'une infection provoquee par le virus de l'hepatite c
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
MY149395A (en) Pharmaceutical compound capable of induce immune protective response against dengue virus having the capsid protein of the dengue virus
FR15C0080I2 (fr) Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52
WO2007076091A3 (fr) Traitement d’infections virales utilisant un inhibiteur de facteur tissulaire
EP1539938A4 (fr) Virus gb-b (gbv-b) chimerique
WO2006019841A3 (fr) S
AU2003240866A1 (en) Antibodies, peptides and vaccines against hiv-1 virus
HK1103634A (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
WO2006052820A3 (fr) Vaccin anti hiv (virus de l'immunodeficience humaine)
WO2008070332A3 (fr) Vaccin contre la grippe féline et procédé d'utilisation